Louisiana legislation · 2026 Regular Session
Louisiana HB766: INSURANCE/HEALTH: Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
Status: Signed into law, June 8, 2026
What the bill says
An act To amend and reenact R.S. 22:999.1, relative to health insurance coverage; to establish guidelines for the coverage of orally administered anti-cancer medications; to ensure parity between orally administered and intravenously administered or injected anticancer medications; to impose prohibitions on cost-sharing, utilization management, and copayment adjustment programs; to provide for definitions; to provide for applicability; and to provide for related matters.
From the introduced text:
AN ACT To amend and reenact R.S. 22:999.1, relative to health insurance coverage; to establish guidelines for the coverage of orally administered anti-cancer medications; to ensure parity between orally administered and intravenously administered or injected anticancer medications; to impose prohibitions on cost-sharing, utilization management, and copayment adjustment programs; to provide for definitions; to provide for applicability; and to provide for related matters. Be it enacted by the Legislature of Louisiana: Section 1. R.S. 22:999.1 is hereby amended and reenacted to read as follows: §999.1. Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications A. It is hereby declared that the public policy of this state is that every person within this state with a health insurance coverage plan that provides coverage for cancer treatment shall have access to the type of covered medication used to treat his the insured's cancer, as such a decision affects the person's overall, long-term health and quality of life. It is also declared that orally administered anti-cancer medications, although very effective in killing or slowing the growth of cancerous cells, have high out-of-pocket costs to the covered person, impacting the decision of physicians to prescribe such medications, thus restricting patient access to life-saving oral anti-cancer medications. It is further declared that physicians must be able to Page 1 of CODING: Words …